97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

21 trials found

diseases per page:

Showing 1 to 10 of 21 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01287195 (ClinicalTrials.gov)	April 7, 2011	28/1/2011	Oral OKT3 for the Treatment of Active Ulcerative Colitis	Oral Anti-CD3 for the Treatment of Active Ulcerative Colitis	Ulcerative Colitis	Drug: Oral OKT3;Drug: Omeprazole	Brigham and Women's Hospital	NULL	Completed	18 Years	65 Years	All	6	Phase 1/Phase 2	United States
2	EUCTR2005-003707-37-BE (EUCTR)	25/05/2007	18/12/2006	A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subject ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subject ...	Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) MedDRA version: 9.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Belgium;Austria
3	EUCTR2005-003707-37-AT (EUCTR)	09/05/2007	03/01/2007	A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subject ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subject ...	Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) MedDRA version: 9.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Belgium;Austria
4	EUCTR2005-003482-17-GB (EUCTR)	26/02/2007	01/02/2006	A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects ...	A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC) MedDRA version: 9.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	165	Phase 2	United Kingdom;Spain;Ireland;Italy;Greece
5	EUCTR2005-003481-42-GR (EUCTR)	30/01/2007	24/11/2006	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC) MedDRA version: 9.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	80		Hungary;Germany;Czech Republic;Slovakia;Spain;Ireland;Italy;Greece
6	EUCTR2005-003482-17-GR (EUCTR)	30/01/2007	24/11/2006	A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects ...	A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC) MedDRA version: 9.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United Kingdom;Spain;Ireland;Italy;Greece
7	EUCTR2005-003482-17-ES (EUCTR)	26/05/2006	15/03/2006	A Phase 2, Randomized, Double-blind, Multicenter, Dose-Exploration Study of Visilizumab in Subjects ...	A Phase 2, Randomized, Double-blind, Multicenter, Dose-Exploration Study of Visilizumab in Subjects ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC) MedDRA version: 8.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United Kingdom;Ireland;Spain;Italy;Greece
8	EUCTR2005-003481-42-ES (EUCTR)	26/05/2006	15/03/2006	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC)Colitis ulcerosa refractaria a esteróides ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	80		Hungary;Germany;Czech Republic;Slovakia;Ireland;Spain;Italy;Greece
9	EUCTR2005-003481-42-SK (EUCTR)	21/04/2006	25/11/2005	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC)	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	Protein Design Labs, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	80	Phase 2	Czech Republic;Hungary;Slovakia;Greece;Spain;Ireland;Austria;Germany
10	EUCTR2005-003481-42-HU (EUCTR)	04/04/2006	28/11/2005	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intrave ...	Intravenous steroid-refractory ulcerative colitis (IVSR-UC) MedDRA version: 9.0;Level: LLT;Classific ...	Product Name: Visilizumab (Nuvion) Product Code: HuM291 INN or Proposed INN: Visilizumab Other descripti ...	PDL BioPharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	80		Hungary;Germany;Czech Republic;Slovakia;Spain;Ireland;Italy;Greece

First Previous1 2 3Next Last